GMED Globus Medical
$66.89 -2.49%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-2.49%
YTD
-23.40%
P/E
16.97
P/B
2.57
ROE
11.6%
Div yield
—
Beta
0.87
Market cap
$9.1B
RSI (14)
35
Next earnings
Feb 22, 2027
Same sector · Health Care
Compare GMED with NVO and JNJ →Follow GMED in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$68.44
Close
$66.89
Day high
$69.54
Day low
$66.63
Volume
1.5M
Latest headlines
Globus Medical (GMED) Is A Key Player In Magnetic Navigation Surgical Robots
Yahoo Finance · Nov 20
Is Globus Medical (GMED) Still Undervalued Following Its Jefferies London Healthcare Conference Update?
Yahoo Finance · Nov 20
The Zacks Analyst Blog Highlights Hinge Health, OPKO Health, Globus Medical and Merit Medical Systems
Yahoo Finance · Nov 19
Global Magnetic Navigation Surgical Robot Market 2026 | Capitalize on 14.1% CAGR Through 2030 as Medtronic, Stereotaxis, Globus Medical, and MicroPort Advance Precision Surgery
Yahoo Finance · Nov 18
Can Globus Medical Stock Rally 30% After This Dip?
Yahoo Finance · Nov 17
GMED Q3 2026 deep dive: product launch delays and Nevro drag outlook, margin improvement offsets
Yahoo Finance · Nov 10
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Nov 5, 2026 View → 8-K Nov 5, 2026 View → 10-Q Aug 6, 2026 View → 8-K Aug 6, 2026 View → 8-K Jun 4, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell GMED. Try it in the Lab to size a position and see the risk.